Member Info for Tonnacombe

Puts a 10p floor underneath the share price which is good, however , the in response to market comment probably implies the MM got to close their naked shorts on the cheap. Not so good imho

Falcon Australia has received a A$4.7 million (~US$3 million) research and development tax offset in cash.

Easy to miss the above one liner

Pulled!! Is the rumour, IMM not interested in price they were offering Some big institutional investors were lined up who wanted in, one for a million gbp, maybe you noticed share volatility elsewhere as they sought to gather funds, Zen , Yu spring to mind. So don't suppose they now longer want to invest do you?

Open market buying for institutional types it seems! Just as it should be, after all, where were you when this was apparently going under! Gotta love these rumours eh ;)

We are extremely encouraged about the potential of the current stimulation program based on strong gas shows and other data observed whilst drilling. In addition, the experienced US operator, Liberty Energy, have shown the efficiencies they can achieve which will provide us with the greatest opportunity for the best possible outcomes from this stimulation program. We look forward to updating the market on the IP30 flow test results as soon as they become available.”

Premier Miton into a placing elsewhere for a million, think that's what's driving the share price down, expecting a TR1 to confir

Https://m.youtube.com/watch?v=PW_KdHIOLe4

Zak calling 1.5p as first target

Of course you could also apply for residency.

https://www.fragomen.com/insights/russia-relaxed-entry-visa-temporary-residence-permit-requirements-in-effect.html

Your Analogy is somewhat irrelevant stockcheck.

America First Rider.

"Weaker Case" had a Malaysian coal miner once , cut and dry case, court case went to Washington they lost.

With Americans geo political stuff can and does get in the way, if America wants Tunisia to take Palestine refugees or some other agenda, a military base perhaps, then all bets are off. Hedge your bets now is my thoughts, your money though you decide.

The dissapoited 30% are far more likely to leave a review then the 70% who achieved success unfortunately, that's perhaps more of an issue.

Cloggies paying 14p

Buy more shares in a company where the ceo used to be a forklift driver?

Take a trip to Kitsmeade, most of the kit is parked up idle, do some research people.

Oh my days in, what a steal!

Noting the above, the Company currently anticipates product sales and royalties in FY25 will be approximately 50% lower than previously expected

Tin hat day.

?? Think it's 13p in Norway

https://live.euronext.com/en/product/equities/CA98936C8584-MERK

I am!! Love a bun fight

SP movement today is imm broker giving it their best shot to tank share price below 4p, as every broker known to man would love to do a raise here atm. BUY goes up tomorrow imho.

I'm a buyer btw if it does!

This shouldn't be 4m mcap.

The financial terms included a signing fee of $0.5m to acquire the license and $0.5m on completion of the human volunteer Phase 1/1b study; TheraCryf would provide data to support Stalicla's clinical trials and both would contribute to the costs of supplying SFX-01 and placebo for these trials. Thereafter, milestone payments that reflect progress by Stalicla in their development programme up to commercial launch amount to $26.5m, including $5m on grant of IND by the FDA (originally anticipated by the end of 2024). Total milestones of up to $160.5m are payable. Royalties payable to TheraCryf on sales are in the low to medium double-digit range in all scenarios, including on-licensing by Stalicla and use of SFX-01 in further licensed indications.